Research Topics
Species | Jonathan P PicciniSummaryAffiliation: Duke University Medical Center Country: USA Publications
| Collaborators
|
Detail Information
Publications
Use of cardiac resynchronization therapy in patients hospitalized with heart failureJonathan P Piccini
Duke Clinical Research Institute, Durham, NC 27715, USA
Circulation 118:926-33. 2008....
Optimal timing of implantable cardioverter-defibrillator implantation after myocardial infarction: a decision analysisJonathan P Piccini
Duke Clinical Research Institute and the Duke University School of Medicine, Durham, North Carolina 27705, USA
J Cardiovasc Electrophysiol 21:791-8. 2010..The optimal timing of implantable cardioverter defibrillator (ICD) placement for the primary prevention of sudden cardiac death after myocardial infarction (MI) remains unknown...
Outcomes After Cardioversion and Atrial Fibrillation Ablation in Patients Treated With Rivaroxaban and Warfarin in the ROCKET AF TrialJonathan P Piccini
Duke Clinical Research Institute, Duke University Medical Center, Durham, North Carolina Electronic address
J Am Coll Cardiol 61:1998-2006. 2013..This study sought to investigate the outcomes following cardioversion or catheter ablation in patients with atrial fibrillation (AF) treated with warfarin or rivaroxaban...
Renal Dysfunction as a Predictor of Stroke and Systemic Embolism in Patients With Nonvalvular Atrial Fibrillation: Validation of the R2CHADS2 Index in the ROCKET AF (Rivaroxaban Once-daily, oral, direct factor Xa inhibition Compared with vitamin K antagonJonathan P Piccini
MHS, Division of Cardiology, Duke University Medical Center, Duke Clinical Research Institute, PO Box 17969, Durham, NC 27710
Circulation 127:224-32. 2013..We sought to define the factors associated with the occurrence of stroke and systemic embolism in a large, international atrial fibrillation (AF) trial...
Sustained ventricular tachycardia and ventricular fibrillation complicating non-ST-segment-elevation acute coronary syndromesJonathan P Piccini
Division of Cardiology, Duke Clinical Research Institute, Duke University Medical Center, PO Box 17969, Durham, NC 27705, USA
Circulation 126:41-9. 2012..However, the incidence and prognosis of sustained ventricular tachycardia/ventricular fibrillation (VT/VF) in contemporary non-ST-segment-elevation (NSTE) ACS populations are not well described...
Predictors of sudden cardiac death change with time after myocardial infarction: results from the VALIANT trialJonathan P Piccini
Division of Cardiology, Duke Clinical Research Institute, Duke University Medical Center, Durham, NC 27705, USA
Eur Heart J 31:211-21. 2010..To determine whether predictors of sudden cardiac death (SCD) vary with time after myocardial infarction (MI)...
Oral factor Xa inhibitors for the prevention of stroke in atrial fibrillationJonathan P Piccini
Duke Clinical Research Institute, Duke University Medical Center, Durham, North Carolina, USA
Curr Opin Cardiol 25:312-20. 2010..Consequently, much research has been focused on finding an alternative to warfarin. We review the potential alternatives in development and evaluate the current evidence concerning their safety and efficacy...
Antiarrhythmic drug therapy for sustained ventricular arrhythmias complicating acute myocardial infarctionJonathan P Piccini
Duke Clinical Research Institute, Duke University Medical Center, Durham, NC, USA
Crit Care Med 39:78-83. 2011..The objective of this analysis was to describe the survival of patients with sustained ventricular tachycardia/ventricular fibrillation after myocardial infarction according to antiarrhythmic drug treatment...
Mortality benefits from implantable cardioverter-defibrillator therapy are not restricted to patients with remote myocardial infarction: an analysis from the Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT)Jonathan P Piccini
Division of Cardiology, Duke University Medical Center, Durham, North Carolina 27710, USA
Heart Rhythm 8:393-400. 2011....
Outcomes registry for better informed treatment of atrial fibrillation: rationale and design of ORBIT-AFJonathan P Piccini
Duke Clinical Research Institute, Durham, NC, USA
Am Heart J 162:606-612.e1. 2011..Data on contemporary treatment patterns and outcomes associated with AF in clinical practice are limited...
Relation of mortality to failure to prescribe beta blockers acutely in patients with sustained ventricular tachycardia and ventricular fibrillation following acute myocardial infarction (from the VALsartan In Acute myocardial iNfarcTion trial [VALIANT] ReJonathan P Piccini
Division of Cardiology, Department of Medicine, and Duke Clinical Research Institute, Duke University Medical Center, Durham, NC, USA
Am J Cardiol 102:1427-32. 2008..Unfortunately, beta blockers were underused acutely in patients with sustained VT/VF...
Comparative efficacy of dronedarone and amiodarone for the maintenance of sinus rhythm in patients with atrial fibrillationJonathan P Piccini
Division of Cardiology, Duke Clinical Research Institute, Duke University Medical Center, Durham, North Carolina 27710, USA
J Am Coll Cardiol 54:1089-95. 2009..We sought to compare the efficacy and safety of dronedarone versus amiodarone for the prevention of recurrent atrial fibrillation (AF)...
Amiodarone for the prevention of sudden cardiac death: a meta-analysis of randomized controlled trialsJonathan P Piccini
Division of Cardiology, Duke Clinical Research Institute, Duke University Medical Center 31115, Durham, NC 27710, USA
Eur Heart J 30:1245-53. 2009..There are conflicting data regarding the efficacy and safety of amiodarone for the prevention of SCD...
Rivaroxaban, an oral direct factor Xa inhibitorJonathan P Piccini
Duke University Medical Center, Duke Clinical Research Institute, 2400 Pratt Street, 7581, Durham, NC 27705, USA
Expert Opin Investig Drugs 17:925-37. 2008..The drug may have its greatest impact in providing a much-needed and attractive alternative to warfarin. Further data (especially large Phase III trials) are required...
Early sustained ventricular arrhythmias complicating acute myocardial infarctionJonathan P Piccini
Duke Clinical Research Institute, Duke University Medical Center, Durham, NC 27715, USA
Am J Med 121:797-804. 2008..The objective of this analysis was to identify predictors of sustained ventricular arrhythmias after acute MI and to determine the influence of successful revascularization on in-hospital mortality...
Outcomes of Medicare beneficiaries undergoing catheter ablation for atrial fibrillationJonathan P Piccini
Duke Clinical Research Institute, PO Box 17969, Durham, NC 27715, USA
Circulation 126:2200-7. 2012..Atrial fibrillation is common among older persons. Catheter ablation is increasingly used in patients for whom medical therapy has failed...
Outcomes of discontinuing rivaroxaban compared with warfarin in patients with nonvalvular atrial fibrillation: analysis from the ROCKET AF trial (Rivaroxaban Once-Daily, Oral, Direct Factor Xa Inhibition Compared With Vitamin K Antagonism for Prevention oManesh R Patel
Duke Clinical Research Institute, Duke University Medical Center, Durham, North Carolina, USA
J Am Coll Cardiol 61:651-8. 2013..The purpose of this study was to understand the possible risk of discontinuation in the context of clinical care...
Rivaroxaban versus warfarin in nonvalvular atrial fibrillationManesh R Patel
Duke Clinical Research Institute, Duke University Medical Center, Durham, NC 27705, USA
N Engl J Med 365:883-91. 2011..Rivaroxaban, an oral factor Xa inhibitor, may provide more consistent and predictable anticoagulation than warfarin...
Antithrombotic therapy for atrial fibrillation and coronary artery disease in older patientsConnie N Hess
Duke Clinical Research Institute, Durham, NC 27705, USA
Am Heart J 164:607-15. 2012..Balancing safe and effective use of aspirin, clopidogrel, and warfarin in this population is important...
International variation in use of oral anticoagulation among heart failure patients with atrial fibrillationJorge Suarez
Duke Clinical Research Institute, Duke University Medical Center, Durham, NC 27715, USA
Am Heart J 163:804-11. 2012..We sought to characterize patient factors and regional variations associated with vitamin K antagonist (VKA) use in patients with heart failure (HF) and atrial fibrillation (AF) in areas outside the United States and Europe...
Predictors of mortality in patients with chronic kidney disease and an implantable defibrillator: an EPGEN substudyEric S Williams
Division of Cardiology, Duke University Medical Center, Durham, NC 27710, USA
Europace 13:1717-22. 2011..Clinical trials of the implantable cardioverter-defibrillator (ICD) have demonstrated a survival benefit over medical therapy for the prevention of sudden cardiac death, but its benefit in patients with concomitant CKD is unclear...
Quality of care for atrial fibrillation among patients hospitalized for heart failureJonathan P Piccini
Duke Clinical Research Institute, Durham, North Carolina 27715, USA
J Am Coll Cardiol 54:1280-9. 2009..This study sought to examine quality of care and warfarin use at discharge in patients with atrial fibrillation (AF) and heart failure (HF)...
Safety and effectiveness of antithrombotic strategies in older adult patients with atrial fibrillation and non-ST elevation myocardial infarctionEmil L Fosbol
Duke Clinical Research Institute, Duke University Medical Center, Durham, NC 27705, USA
Am Heart J 163:720-8. 2012..We aimed to study the comparative safety and effectiveness of various antithrombotic treatment strategies among older adults with non-ST elevation myocardial infarction (NSTEMI) and atrial fibrillation (AF)...
Impact of global geographic region on time in therapeutic range on warfarin anticoagulant therapy: data from the ROCKET AF clinical trialDaniel E Singer
Department of Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, MA 02114, USA
J Am Heart Assoc 2:e000067. 2013..Time in therapeutic range (TTR) is a widely cited measure of the quality of VKA therapy. We sought to identify factors associated with TTR in a large, international clinical trial...
Single-photon emission computed tomography myocardial perfusion imaging and the risk of sudden cardiac death in patients with coronary disease and left ventricular ejection fraction>35%Jonathan P Piccini
Division of Cardiology, Department of Medicine, Duke University Medical Center, Durham, North Carolina 27710, USA
J Am Coll Cardiol 56:206-14. 2010....
Pulmonary vein isolation for the maintenance of sinus rhythm in patients with atrial fibrillation: a meta-analysis of randomized, controlled trialsJonathan P Piccini
Division of Cardiology, Duke Clinical Research Institute, Duke University Medical Center, Durham, NC 27715, USA
Circ Arrhythm Electrophysiol 2:626-33. 2009..The efficacy and safety of pulmonary vein isolation (PVI) compared with medical therapy remain in question...
Pharmacotherapy in Medicare beneficiaries with atrial fibrillationJonathan P Piccini
Duke Clinical Research Institute, Duke University School of Medicine, Durham, North Carolina, USA
Heart Rhythm 9:1403-8. 2012..There are limited data regarding national patterns of pharmacotherapy for atrial fibrillation (AF) among older patients. Drug exposure data are now captured for Medicare beneficiaries enrolled in prescription drug plans...
Relationship of sustained ventricular tachyarrhythmias to outcomes in patients undergoing primary percutaneous coronary intervention with varying underlying baseline riskRajendra H Mehta
Duke Clinical Research Institute, Durham, NC 27715, USA
Am Heart J 161:782-9. 2011....
Surgical Maze procedure as a treatment for atrial fibrillation: a meta-analysis of randomized controlled trialsMelissa H Kong
Duke University Medical Center, Durham, NC 27710, USA
Cardiovasc Ther 28:311-26. 2010..Large RCTs defining rates of freedom from AF without AADs postprocedure, are still needed to evaluate outcomes and determine the appropriate role for surgical Maze procedures in the management of AF...
Cardiac conduction system disease after transcatheter aortic valve replacementBenjamin A Steinberg
Division of Cardiology, Department of Medicine, Durham, NC
Am Heart J 164:664-71. 2012....
Single-photon emission computed tomography myocardial perfusion defects are associated with an increased risk of all-cause death, cardiovascular death, and sudden cardiac deathJonathan P Piccini
Division of Cardiology, Department of Medicine, Duke University Medical Center, Durham, NC 27710, USA
Circ Cardiovasc Imaging 1:180-8. 2008..However, it is unknown whether single-photon emission computed tomography myocardial perfusion imaging can identify patients at increased risk of sudden cardiac death (SCD)...
Extent of and reasons for nonuse of implantable cardioverter defibrillator devices in clinical practice among eligible patients with left ventricular systolic dysfunctionNancy M Allen LaPointe
Duke University Medical Center, Duke Clinical Research Institute, Durham, NC 27705, USA
Circ Cardiovasc Qual Outcomes 4:146-51. 2011..The extent and documented reasons for nonuse of ICDs among patients with left ventricular systolic dysfunction are unknown...
Antithrombotic therapy in atrial fibrillation: guidelines translated for the clinicianRenato D Lopes
Duke Clinical Research Institute, Duke University Medical Center, Durham, NC 27710, USA
J Thromb Thrombolysis 26:167-74. 2008....
Impact of using a telescoping-support catheter system for left ventricular lead placement on implant success and procedure time of cardiac resynchronization therapyKevin P Jackson
Division of Clinical Cardiac Electrophysiology, Department of Medicine, Duke University Medical Center, Durham, North Carolina
Pacing Clin Electrophysiol 36:553-8. 2013..We sought to evaluate the impact of an LV lead implant approach using telescoping-support catheters (group TS) on success rate, lead location, and procedural time compared to standard over-the-wire implant techniques (group OTW)...
Rate versus rhythm control for management of atrial fibrillation in clinical practice: results from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF) registryBenjamin A Steinberg
Duke University Medical Center, Durham, NC 27715, USA
Am Heart J 165:622-9. 2013..All patients with atrial fibrillation (AF) require optimization of their ventricular rate. Factors leading to use of additional rhythm control in clinical practice have not been thoroughly defined...
Incidence and prevalence of atrial fibrillation and associated mortality among Medicare beneficiaries, 1993-2007Jonathan P Piccini
Duke Clinical Research Institute, Duke University School of Medicine, Durham, NC 27715, USA
Circ Cardiovasc Qual Outcomes 5:85-93. 2012..The frequency of AF increases with age, but representative national data about incidence and prevalence are limited. We examined the annual incidence, prevalence, and mortality associated with AF among older persons...
Prognostic significance of postprocedural sustained ventricular tachycardia or fibrillation in patients undergoing primary percutaneous coronary intervention (from the HORIZONS-AMI Trial)Rajendra H Mehta
Duke Clinical Research Institute, Durham, North Carolina, USA
Am J Cardiol 109:805-12. 2012..Further studies are required to address the prognostic significance of VT/VF in patients with STEMI undergoing PPCI...
Use of ventricular synchronized triggered atrial pacing to facilitate hemodynamic support during mapping and catheter ablation of ventricular vachycardiaJonathan P Piccini
Cardiac Electrophysiology Section, Division of Cardiology, Duke University Medical Center, Durham, North Carolina, USA
J Cardiovasc Electrophysiol 22:1174-8. 2011..Thus, VSTAP is a readily available and noninvasive technique that may provide adequate hemodynamic support during catheter ablation of unstable VT...
Efficacy of adjunctive ablation of complex fractionated atrial electrograms and pulmonary vein isolation for the treatment of atrial fibrillation: a meta-analysis of randomized controlled trialsMelissa H Kong
Duke University Medical Center, Clinical Cardiac Electrophysiology Section of the Division of Cardiovascular Diseases, DUMC Box 31294, Durham, NC 27710, USA
Europace 13:193-204. 2011..The ablation of complex fractionated atrial electrograms (CFAEs) has been proposed as an adjunctive strategy to improve the maintenance of sinus rhythm after PVI. Our objective was to analyse the efficacy of adjunctive CFAE ablation...
Mode of induction of ventricular tachycardia and prognosis in patients with coronary disease: the Multicenter UnSustained Tachycardia Trial (MUSTT)Jonathan P Piccini
Duke Clinical Research Institute, Durham, North Carolina, USA
J Cardiovasc Electrophysiol 20:850-5. 2009..However, it is unknown whether the mode of VT induction is associated with long-term prognosis...
Remote monitoring of implantable cardioverter defibrillators versus quarterly device interrogations in clinic: results from a randomized pilot clinical trialSana M Al-Khatib
Duke Clinical Research Institute, Duke University Medical Center, Durham, North Carolina 27710, USA
J Cardiovasc Electrophysiol 21:545-50. 2010..We sought to determine whether remote monitoring of ICDs improves patient outcomes compared with quarterly device interrogations in clinic...
Retrograde ascending aortic dissection as an early complication of thoracic endovascular aortic repairJudson B Williams
Division of Thoracic and Cardiovascular Surgery, Duke University Medical Center, Durham, NC 27710, USA
J Vasc Surg 55:1255-62. 2012..This study examines the incidence, etiology, and outcome of this event...
The S1103Y cardiac sodium channel variant is associated with implantable cardioverter-defibrillator events in blacks with heart failure and reduced ejection fractionAlbert Y Sun
Division of Cardiovascular Diseases, Department of Medicine, Duke University Medical Center, Durham, NC, USA
Circ Cardiovasc Genet 4:163-8. 2011..We hypothesized that the S1103Y cardiac sodium channel SCN5A variant influences the propensity for ventricular arrhythmias in black patients with heart failure and reduced ejection fraction...
Current challenges in the evaluation of cardiac safety during drug development: translational medicine meets the Critical Path InitiativeJonathan P Piccini
Duke Clinical Research Institute and Duke University Medical Center, Durham, NC 27705, USA
Am Heart J 158:317-26. 2009..Priority pursuit of these consensus-based directions should facilitate both safer drugs and accelerated access to new drugs, as concomitant public health benefits...
Cryoablation of atrial fibrillationJonathan P Piccini
Duke Center for Atrial Fibrillation Cardiac Electrophysiology Section, Division of Cardiology, Duke University Medical Center and Duke Clinical Research Institute, Durham, NC, USA
J Interv Card Electrophysiol 32:233-42. 2011....
Predictors of appropriate implantable defibrillator therapies in patients with arrhythmogenic right ventricular dysplasiaJonathan P Piccini
Division of Cardiology, Department of Medicine, The Johns Hopkins Hospital, 600 N. Wolfe Street, Carnegie 592, Baltimore, MD 21287, USA
Heart Rhythm 2:1188-94. 2005..Further research is needed to confirm that a low-risk subset of patients who may not require ICD placement can be identified...
Rationale and design of the Duke Electrophysiology Genetic and Genomic Studies (EPGEN) biorepositoryJason I Koontz
Department of Medicine, Duke University Medical Center, Durham, NC 27710, USA
Am Heart J 158:719-25. 2009..Many arrhythmias are known to have a heritable component, but the degree to which genetic variation contributes to disease risk and morbidity is poorly understood...
Device therapy in heart failure patients with chronic kidney diseaseLeon A Cannizzaro
Department of Medicine, Duke University Medical Center, Durham, North Carolina, USA
J Am Coll Cardiol 58:889-96. 2011..Given this lack of clear evidence, pragmatic clinical trials and comparative effectiveness studies are needed to help identify the appropriate use of ICD and CRT devices in this high-risk population of patients with HF and CKD...
Electrocardiographic findings over time in arrhythmogenic right ventricular dysplasia/cardiomyopathyJonathan P Piccini
Division of Cardiology, Department of Medicine, Johns Hopkins Medical Institutions, Baltimore, Maryland, USA
Am J Cardiol 96:122-6. 2005..Over a median of 43 months, 89% of the patients had evidence of progression, with S-wave prolongation being the most prevalent marker of ECG progression...
